Lytix Biopharma announces approval to expand the ATLAS-IT-05 study to Europe ...Middle East

PR Newswire - News
Lytix Biopharma announces approval to expand the ATLAS-IT-05 study to Europe
OSLO, Norway, Sept. 7, 2022 /PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, today announces the regulatory approval from European authorities to commence the ATLAS-IT-05 study in three European countries. ATLAS-IT-05 is a Phase...

Hence then, the article about lytix biopharma announces approval to expand the atlas it 05 study to europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lytix Biopharma announces approval to expand the ATLAS-IT-05 study to Europe )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News